Answers are grounded in this paper and cite their sources.
Identifies structural properties of modified nucleoside in E. coli tRNA, suggesting its biochemical origins.
A modified nucleoside, N + , was isolated from Escherichia coii tRNA, and its structure was, determined to be N‐[N‐[(9‐β‐D‐ribofuranosylpurin‐6‐yl)carbamoyl]threonyl]‐2‐amido‐2‐hydroxymethylpropane‐1,3‐diol. The structure determination of N + was based on its ultraviolet absorption, nuclear magnetic resonance spectrum, high and low‐resolution mass spectra, and its properties following chemical degradation. The ultraviolet absorption spectra of N + closely resembled the spectra of N‐[N‐[(9‐β‐ d ‐ribofuranosylpurin‐6‐yl)carbamoyl]threonyl]amide, suggesting that N + is a derivative of the latter. Alkaline and acid hydrolysis resulted in the formation of N‐[N‐(9‐β‐ d ‐ribofuranosylpurin‐6‐yl)carbamoyl)threonine. Low and high‐resolution mass spectrometry of the trimethylsilyl derivative of N + indicated the presence of an aminobutanetriol moiety, NH 2 C 4 H 6 (OH) 3 , attached to the threonine through an amide linkage. The aminobutanetriol structure was determined to be NH 2 ‐C‐(CH 2 OH) 3 by analysis of the nuclear magnetic resonance spectrum of N + , and by direct comparison of the mass spectrum of the side chain with that of an authentic compound, following acid hydrolysis of N + and gas chromatography/mass spectrometry. It is very likely that the aminobutanetriol moiety is derived from tris(hydroxymethyl)aminomethane, namely Tris buffer, that was added in the medium to suspend E. coli cells. Covalent bonding between tris(hydroxymethyl)‐aminomethane and the threonyl moiety presumably occurs in vivo in E. coli cells, rather than in vitro during isolation of N + from tRNA.
No takes yet. Share an insight, caveat, or question.
Kasai et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: